Food hypersensitivity: an examination of factors influencing symptoms and temporal changes in the prevalence of sensitization in an adult sample.


Journal

European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070

Informations de publication

Date de publication:
08 2023
Historique:
received: 30 06 2022
accepted: 10 03 2023
revised: 06 03 2023
medline: 3 8 2023
pubmed: 26 3 2023
entrez: 25 3 2023
Statut: ppublish

Résumé

Food hypersensitivity (FHS) is common, but little is known about the factors associated with severe reactions, age of onset and whether sensitization persists. This study examines the factors associated with self-reported severe food reactions, onset age and the changes in prevalence of sensitization to foods over time in an adult sample. We used data from adults taking part in the European Community Respiratory Health Survey (ECRHS) III (2010-2014) who provided information on food hypersensitivity, including symptoms, suspected culprit food and onset age (n = 4865). A subsample from six countries had serum food-specific IgE tested for 25 core foods and also in 10 years earlier (ECRHS II). We applied logistic regression and McNemar's test for analyses. The prevalence of self-reported FHS was 13.5% at ECRHS III. Of those providing information on symptoms (n = 611), 26.4% reported severe reactions. About 80% of 1033 reported food-specific reactions (reported by 596 participants) began after age 15. History of asthma (odds ratio OR 2.12 95% confidence interval CI 1.13-3.44) and a younger age of onset of FHS (OR 1.02, 95% CI 1.01-1.03, per year) were associated with higher risks of a lifetime experience of severe food reactions. In the subsample with IgE tested in both surveys (n = 1612), the overall prevalence of sensitization to foods did not change over 10 years. Our findings support previous observations of more severe food reactions in people with asthma and that most FHS reported by this sample started after age 15. We found no evidence of changes in the prevalence of sensitization to food in adults followed for 10 years.

Sections du résumé

BACKGROUND/OBJECTIVES
Food hypersensitivity (FHS) is common, but little is known about the factors associated with severe reactions, age of onset and whether sensitization persists. This study examines the factors associated with self-reported severe food reactions, onset age and the changes in prevalence of sensitization to foods over time in an adult sample.
SUBJECTS/METHODS
We used data from adults taking part in the European Community Respiratory Health Survey (ECRHS) III (2010-2014) who provided information on food hypersensitivity, including symptoms, suspected culprit food and onset age (n = 4865). A subsample from six countries had serum food-specific IgE tested for 25 core foods and also in 10 years earlier (ECRHS II). We applied logistic regression and McNemar's test for analyses.
RESULTS
The prevalence of self-reported FHS was 13.5% at ECRHS III. Of those providing information on symptoms (n = 611), 26.4% reported severe reactions. About 80% of 1033 reported food-specific reactions (reported by 596 participants) began after age 15. History of asthma (odds ratio OR 2.12 95% confidence interval CI 1.13-3.44) and a younger age of onset of FHS (OR 1.02, 95% CI 1.01-1.03, per year) were associated with higher risks of a lifetime experience of severe food reactions. In the subsample with IgE tested in both surveys (n = 1612), the overall prevalence of sensitization to foods did not change over 10 years.
CONCLUSION
Our findings support previous observations of more severe food reactions in people with asthma and that most FHS reported by this sample started after age 15. We found no evidence of changes in the prevalence of sensitization to food in adults followed for 10 years.

Identifiants

pubmed: 36964270
doi: 10.1038/s41430-023-01284-w
pii: 10.1038/s41430-023-01284-w
pmc: PMC10393775
doi:

Substances chimiques

Allergens 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

833-840

Subventions

Organisme : Medical Research Council
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1920-1928.e11
pubmed: 30898689
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):713-20
pubmed: 27133095
JAMA Netw Open. 2019 Jan 4;2(1):e185630
pubmed: 30646188
Pediatr Allergy Immunol. 2008 Mar;19(2):173-9
pubmed: 18257905
Pediatr Allergy Immunol. 2021 Nov;32(8):1730-1742
pubmed: 34142390
Pediatr Allergy Immunol. 2009 Nov;20(7):686-92
pubmed: 19594854
Eur Respir J. 1994 May;7(5):954-60
pubmed: 8050554
Clin Rev Allergy Immunol. 2019 Oct;57(2):244-260
pubmed: 30370459
Eur J Clin Nutr. 2001 Apr;55(4):298-304
pubmed: 11360135
Clin Transl Allergy. 2019 Apr 01;9:22
pubmed: 30976385
Eur Respir J. 2002 Nov;20(5):1071-9
pubmed: 12449157
Clin Transl Allergy. 2020 Jun 17;10:22
pubmed: 32551040
Allergy. 2014 Mar;69(3):365-71
pubmed: 24372074
Allergy. 2010 Sep;65(9):1182-8
pubmed: 20180791
Allergy. 2016 Sep;71(9):1241-55
pubmed: 27138061
J Allergy Clin Immunol. 2016 Jun;137(6):1788-1795.e9
pubmed: 26586040
PLoS One. 2014 Jul 17;9(7):e102809
pubmed: 25033453
Ann Allergy Asthma Immunol. 1996 Oct;77(4):327-32
pubmed: 8885811
Eur J Clin Nutr. 2004 Dec;58(12):1621-5
pubmed: 15213708
World Allergy Organ J. 2019 Oct 31;12(10):100066
pubmed: 31719946
PLoS One. 2014 Jan 10;9(1):e85333
pubmed: 24427301

Auteurs

Holly C Y Lam (HCY)

National Heart and Lung Institute, Imperial College London, London, UK. ching.lam@imperial.ac.uk.
MRC Centre for Environment and Health, Imperial College London, London, UK. ching.lam@imperial.ac.uk.

Catherine Neukirch (C)

Service de Pneumologie, AP-HP, Hôpital Bichat, Université de Paris, INSERM 1152, F-75018, Paris, France.

Christer Janson (C)

Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Judith Garcia-Aymerich (J)

Barcelona Institute of Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Michael Clausen (M)

Children's Hospital and Department of Allergy, Landspitali University Hospital, 101, Reykjavik, Iceland.

N Sabrina Idrose (NS)

Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC, Australia.
Centre for Food and Allergy Research, Murdoch Children's Research Institute, Parkville, VIC, 3052, Australia.

Pascal Demoly (P)

Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France.

Randi J Bertelsen (RJ)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway.

Lidia C Ruiz (LC)

Social Epidemiology and Health Policy (SEHPO), Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.

Chantal Raherison (C)

University of Bordeaux, INSERM, BPH, U1219, F-33000, Bordeaux, France.

Deborah L Jarvis (DL)

National Heart and Lung Institute, Imperial College London, London, UK.
MRC Centre for Environment and Health, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH